Nancy J.V. Bohannon MD, Med. Corp.
Endocrinology
Dr. Nancy J. Bohannon, MD
|
|
Give Review
Nancy Bohannon is an expert in the field of Endocrinology. She attended University of California Davis School of Medicine. University of California Davis School of Medicine is ranked 43/19 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACE)". Doctor Nancy J. Bohannon, MD is a published doctor as well. She has 14 publications published. The latest was: Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents. She accepts all Medicare patients.
Publications
- Individualized treatment of type 2 Diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician.
- TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic control.
- Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with Diabetes:...
- Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.
- Insulin patch pumps: their development and future in closed-loop systems.
- A review of the response to oral antiDiabetes agents in patients with type 2 Diabetes.
- Overview of the gliptin class (dipeptidyl peptidase-4 inhibitors) in clinical practice.
- Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 Diabetes: results of a 6-month, randomized, compara...
- Insulin therapy for reducing cardiovascular risk in patients with type 2 Diabetes.
- Optimizing insulin regimens in type 1 Diabetes. How to help patients get control of their life.
- Treating dual defects in Diabetes: insulin resistance and insulin secretion.
- Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-Diabetes agents.
Schools
University Of California Davis School Of Medicine
Conditions Treated
- Adrenal Insufficiency
- Diabetes Type 2
- Goiter
- Hyperlipidemia
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACE)
Education
-
UCSF -
California Pacific Medical Center - California Campus -
University of California Davis School of Medicine
Hospital
-
California Pacific Medical Center
Drug Facts
| NPI NUMBER | 1063428001 | |
| NPPES Provider LastName | BOHANNON | |
| NPPES Provider FirstName | NANCY | |
| NPPES Provider ZIPCode | 941104415 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 395.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063428001 |
| Last Name Of The Provider | BOHANNON |
| First Name Of The Provider | NANCY |
| View All |
Similar Doctors
|
|
Dr. Merl A. Charles, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel D. Bikle, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Philip H. Frost, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip R. Madvig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Rushakoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nathan Becker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Kimmerling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mickie H. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry M. Sherman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Myrna L. Soriano, MD
This Doctor is OpenDoctor Recommended.
|